Diabetic macular edema
- PMID: 20703045
- DOI: 10.1159/000320075
Diabetic macular edema
Abstract
Diabetic macular edema (DME), defined as a retinal thickening involving or approaching the center of the macula, represents the most common cause of vision loss in patients affected by diabetes mellitus. In the last few years, many diagnostic tools have been proven useful in the detection and the monitoring of the features characterizing DME. On the other hand, several therapeutic approaches can now be proposed on the basis of the DME-specific characteristics. The aim of the present chapter is to thoroughly delineate the clinical and morpho functional characteristics of DME and its current treatment perspectives. The pathogenesis and the course of DME require a complex approach with multidisciplinary intervention both at the systemic and local levels.
2010 S. Karger AG, Basel
Similar articles
-
Detailed analysis of retinal morphology in patients with diabetic macular edema (DME) randomized to ranibizumab or triamcinolone treatment.Graefes Arch Clin Exp Ophthalmol. 2018 Jan;256(1):49-58. doi: 10.1007/s00417-017-3828-1. Epub 2017 Oct 28. Graefes Arch Clin Exp Ophthalmol. 2018. PMID: 29080915 Free PMC article.
-
Diabetic Macular Edema.Dev Ophthalmol. 2017;58:102-138. doi: 10.1159/000455277. Epub 2017 Mar 28. Dev Ophthalmol. 2017. PMID: 28351052 Review.
-
Practical Lessons from Protocol I for the Management of Diabetic Macular Edema.Dev Ophthalmol. 2017;60:91-108. doi: 10.1159/000459692. Epub 2017 Apr 20. Dev Ophthalmol. 2017. PMID: 28427069 Review.
-
Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.Ophthalmology. 2006 Oct;113(10):1713-9. doi: 10.1016/j.ophtha.2006.05.021. Epub 2006 Aug 4. Ophthalmology. 2006. PMID: 16889833
-
Triple therapy of vitrectomy, intravitreal triamcinolone, and macular laser photocoagulation for intractable diabetic macular edema.Am J Ophthalmol. 2008 Aug;146(2):332-3; author reply 333. doi: 10.1016/j.ajo.2008.04.017. Am J Ophthalmol. 2008. PMID: 18656589 No abstract available.
Cited by
-
Ocular Complications of Diabetes and Therapeutic Approaches.Biomed Res Int. 2016;2016:3801570. doi: 10.1155/2016/3801570. Epub 2016 Mar 28. Biomed Res Int. 2016. PMID: 27119078 Free PMC article. Review.
-
[Navigated focal retinal laser therapy using the NAVILAS® system for diabetic macula edema].Ophthalmologe. 2012 Jul;109(7):692-8. doi: 10.1007/s00347-012-2559-2. Ophthalmologe. 2012. PMID: 22532038 Clinical Trial. German.
-
Ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema: a meta-analysis of randomized controlled trials.PLoS One. 2014 Dec 26;9(12):e115797. doi: 10.1371/journal.pone.0115797. eCollection 2014. PLoS One. 2014. PMID: 25541937 Free PMC article.
-
Diabetic Macular Edema Management: A Review of Anti-Vascular Endothelial Growth Factor (VEGF) Therapies.Cureus. 2024 Jan 21;16(1):e52676. doi: 10.7759/cureus.52676. eCollection 2024 Jan. Cureus. 2024. PMID: 38264181 Free PMC article. Review.
-
Effect of thiamine pyrophosphate on retinopathy induced by hyperglycemia in rats: A biochemical and pathological evaluation.Indian J Ophthalmol. 2016 Jun;64(6):434-9. doi: 10.4103/0301-4738.187666. Indian J Ophthalmol. 2016. PMID: 27488151 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical